Functional CXCR4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells
Open Access
- 15 November 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (22), 11013-11020
- https://doi.org/10.1158/0008-5472.can-06-2006
Abstract
Exposure to tobacco smoke and to mutagenic xenobiotics can cause various types of DNA damage in lung cells, which, if not corrected by DNA repair systems, may lead to deregulation of the cell cycle and, ultimately, to cancer. Genetic variation could thus be an important factor in determining susceptibility to tobacco-induced lung cancer with genetic susceptibility playing a larger role in young-onset cases compared with that in the general population. We have therefore studied 102 single-nucleotide polymorphisms (SNP) in 34 key DNA repair and cell cycle control genes in 299 lung cancer cases diagnosed before the age of 50 years and 317 controls from six countries of Central and Eastern Europe. We have found no association of lung cancer risk with polymorphisms in genes related to cell cycle control, single-strand/double-strand break repair, or base excision repair. Significant associations (P < 0.05) were found with polymorphisms in genes involved in DNA damage sensing (ATM) and, interestingly, in four genes encoding proteins involved in mismatch repair (LIG1, LIG3, MLH1, and MSH6). The strongest associations were observed with heterozygote carriers of LIG1 −7C>T [odds ratio (OR), 1.73; 95% confidence interval (95% CI), 1.13-2.64] and homozygote carriers of LIG3 rs1052536 (OR, 2.05; 95% CI, 1.25-3.38). Consideration of the relatively large number of markers assessed diminishes the significance of these findings; thus, these SNPs should be considered promising candidates for further investigation in other independent populations. (Cancer Res 2006; 66(22): 11062-9)Keywords
This publication has 43 references indexed in Scilit:
- CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironmentBlood, 2006
- Circulating Endothelial Cells, Endothelial Progenitor Cells, and Endothelial Microparticles in CancerNeoplasia, 2006
- The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritisEmerging Therapeutic Targets, 2005
- Marked structural and functional heterogeneity in CXCR4: Separation of HIV‐1 and SDF‐1α responsesImmunology & Cell Biology, 2005
- Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancerInternational Journal of Cancer, 2004
- Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasisThe FASEB Journal, 2004
- Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversityBlood, 2004
- Acute Myeloid LeukemiaHematology-American Society Hematology Education Program, 2004
- Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIVAIDS, 2003
- Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4Journal of Biological Chemistry, 2002